Ming Qian
1500 Qinghua Rd
Changchun, 130021, China
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Protective effects of circPVT1 against D-galactose-induced senescence in HEI-OC1 auditory cells.
Journal: Molecular biology reports
Published: May 19, 2026
Retraction notice to "Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p" [Biomed. Pharmacother. 110 (2019), 825-833].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 11, 2025
ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway.
Journal: Molecular carcinogenesis
Published: September 05, 2023
Epidermal stem cell-derived exosomes promote skin regeneration by downregulating transforming growth factor-β1 in wound healing.
Journal: Stem cell research & therapy
Published: August 24, 2020
MicroRNA-141-3p affected proliferation, chemosensitivity, migration and invasion of colorectal cancer cells by targeting EGFR.
Journal: The international journal of biochemistry & cell biology
Published: June 25, 2019
Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 17, 2018
Enhancement of oxidation resistance via a self-healing boron carbide coating on diamond particles.
Journal: Scientific reports
Published: August 12, 2015
Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
Journal: Oncology reports
Published: October 21, 2014
Synthesis of composites SBA-15 mesoporous particles carrying oxytocin and evaluation of their properties, functions, and in vitro biological activities.
Journal: Cell biochemistry and biophysics
Published: August 21, 2014
Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
Journal: Oncology reports
Published: March 28, 2014
Last Updated: 09/26/2026